4//SEC Filing
FRANCIS LAURA 4
Accession 0001562180-25-004057
CIK 0001459839other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:48 PM ET
Size
22.1 KB
Accession
0001562180-25-004057
Insider Transaction Report
Form 4
SI-BONE, Inc.SIBN
FRANCIS LAURA
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-05-16$19.66/sh−3,785$74,421→ 500,698 total - Sale
Common Stock
2025-05-16$19.48/sh−794$15,467→ 496,399 total - Sale
Common Stock
2025-05-16$19.69/sh−2,028$39,927→ 504,483 total - Sale
Common Stock
2025-05-16$20.01/sh−100$2,001→ 497,501 total - Sale
Common Stock
2025-05-16$19.68/sh−2,231$43,909→ 495,170 total - Sale
Common Stock
2025-05-19$19.49/sh−5,412$105,464→ 490,987 total - Sale
Common Stock
2025-05-16$20.01/sh−250$5,002→ 506,511 total - Sale
Common Stock
2025-05-16$19.68/sh−3,097$60,943→ 497,601 total - Sale
Common Stock
2025-05-16$20.01/sh−100$2,001→ 497,401 total
Holdings
- 302,958(indirect: By Trust)
Common Stock
Footnotes (11)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F10]Includes 418,615 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F11]Shares held by The David & Laura Joint Rev Tr.
- [F2]This transaction was executed in multiple trades at prices ranging from $20.00 USD to $20.01 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.005 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]This transaction was executed in multiple trades at prices ranging from $19.00 USD to $19.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.00 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]This transaction was executed in multiple trades at prices ranging from $18.98 USD to $19.955 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
- [F8]This transaction was executed in multiple trades at prices ranging from $19.26 USD to $19.64 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F9]Includes 2,023 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2025.
Documents
Issuer
SI-BONE, Inc.
CIK 0001459839
Entity typeother
Related Parties
1- filerCIK 0001218802
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 7:48 PM ET
- Size
- 22.1 KB